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Background. Sepsis is an important cause of mortality in newborns. However, a single reliable marker is not available for the
diagnosis of neonatal late-onset sepsis (NLS). The aim of this study is to evaluate the value of serum amyloid A (SAA) and
procalcitonin (PCT) in the diagnosis and follow-up of NLS. Methods. 36 septic and healthy newborns were included in the study.
However, SAA, PCT, TNF-α,I L - 1 β, and CRP were serially measured on days 0, 4, and 8 in the patients and once in the controls.
T¨ ollner’ssepsisscore(TSS)wascalculatedforeachpatient.Results.CRP ,PCT ,andTNF -αlevelsinsepticneonatesateachstudyday
were signiﬁcantly higher than in the controls (P = .001). SAA and IL-1β levels did not diﬀer from healthy neonates. The sensitivity
andspeciﬁcitywere86.8%and97.2%forPCT,83.3%and80.6%forTNF-α,75%and44.4%forSAAonday0.Conclusion.P r ese nt
study suggests that CRP seems to be the most helpful indicator and PCT and TNF-α may be useful markers for the early diagnosis
of NLS. However, SAA, IL-1β, and TSS are not reliable markers for the diagnosis and follow-up of NLS.
Copyright © 2008 Birsen Ucar et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
Sepsis and septic shock in newborn infants have a high risk
of morbidity and mortality. Despite advances in medicine,
diagnosis of neonatal sepsis remains as a major challenge.
Early clinical signs are nonspeciﬁc and the laboratory
criteria are also not fully reliable. Warning signs and
symptoms are often subtle and can easily be confused
with noninfective causes such as apnea, hypothermia,
and acute exacerbation of chroniclung disease. So that
hematological and biochemical markers such as imma-
ture/total neutrophil ratio, platelet count, C-reactive pro-
tein (CRP), various cytokines, procalcitonin (PCT), and
tumornecrosis factor-α (TNF-α) have been proposed as
being useful indicators for early identiﬁcation of septic
infants [1–4]. Recently, SAA that refers to a group of
polymorphic apolipoproteins 12–14kDa, mainly produced
by the liver, has been proposed as a new discriminative
marker of bacterial infection [1, 3–6]. But the results
of these rare studies are contradictory. In this study, we
investigated the value of SAA and procalcitonin levels in
the diagnosis and followup of neonatal late-onset sepsis
(NLS).
2. MATERIAL AND METHODS
Thirty six newborn infants who were diagnosed as having
clinical suspected NLS in the neonatal intensive care unit
at the medical faculty of Eskisehir Osmangazi University
between June 2003 and June 2004 were included in this
prospective study. Thirty six healthy newborns who had
normal clinical and laboratory ﬁndings were included as
a control group. They were selected from the neonatal
unit or well-baby outpatient clinic. Diagnosis of sepsis
was done according to the 2001 International Sepsis Def-
initions Conference criteria. According to this conference,
diagnostic criteria for sepsis in the pediatric population
are signs and symptoms of inﬂammation including arterial
hypotension-decreased capillary reﬁll or mottling cardiac
index >5.5, signiﬁcant edema or positive ﬂuid balance, ileus
plus infection (documented or suspected) with hyper or
hypothermia, tachycardia, and at least one of the following
indications of altered organ function: altered mental status,
acute oliguria, hypoxemia, increased serum lactate level, or
bounding pulses [7]. Laboratory criteria were leukocytosis,
leukopenia, immature leukocyte count >10%, and high CRP
levels [7].2 Mediators of Inﬂammation
Table 1: Demographic ﬁndings in patients and control subjects∗.
Sex Birth weight Delivery Age 5 Apgar
Girls Boys (mean ± SD) SVD C/S Gestational Post natal score
n (%) n (%) (g) n (%) n (%) (mean ± SD) (week) (mean ± SD) (day) mean
Patients group 13 (36.1) 23 (63.8) 2281.9 ±127.1 18 (50) 18 (50) 34.5 ±0.56 .9 ±0.69 . 2
Control group 12 (33.3) 24 (66.6) 2202.1 ±122.6 20 (56) 16 (44) 33.4 ±0.48 ± 0.8 8.9
SVD: Spontan vaginal delivery; C/S: caesarean section. ∗P>. 05.
Table 2: Clinical and laboratory ﬁndings in patients.
n %
A. Clinical parameters
Depressed newborn reﬂexes 30 83.3
Hypotonia 31 86.1
Change of body temperature 26 72.2
–H i g h( >38◦C) 19 52.8
–L o w( <36◦C) 7 19.4
Dyspnoea 26 72.2
Cut is marmoratus 23 63.9
Hepatomegaly 21 58.3
Central cyanosis 20 55.6
Apnea 18 50
Jaundice 15 41.7
Convulsion 8 22.2
Lethargy 5 13.9
Sclerema 5 13.9
B. Laboratory parameters
Disseminated intravascular coagulation (DIC) 5 13.9
Toxic granulation 33 91.7
High I/T ratio 19 52.8
Blood culture 26 72.2
– Coagulase-negative staphylococci 2 5.6
– Staphylococcus aureus 4 11.1
– Klebsiella pneumoniae 13 36.1
– Acinetobacter SPP 2 5.6
– Pseudomonas aeruginosa 1 2.8
– Enterobacter cloaca 2 5.6
– Candida tropicalis 1 2.8
– Streptococcus viridans 1 2.8
Platelet count (mean ± SEM, per mm3) 46777.8 ±10720.6
Leukocyte count (mean ± SEM, per mm3) 19294.4 ±8598
T¨ ollner’s sepsis score (TSS) was calculated for each
patient [8]. This scoring system consists of clinical (skin
color, body temperature, muscle tonus, breath rate, abdom-
inal distension, imperfect microcirculation, and risk fac-
tors) and laboratory (leukocyte and thrombocyte counts,
CRP, immature/total neutrophil ratio) parameters. A point
w a sg i v e nf o re a c hp a r a m e t e r( 0 ,1 ,2 ,o r3 )i nr e s p e c t
of their worsening. For example, 0 for normal muscle
tonus, 1 for hypotonia, 2 for ﬂask tonus, 0 for normal
leukocyte count, 1 for leukocytosis, and 3 for leukopenia.
According to this scoring system, patients who have >10
points were determined as having sepsis. Chest radiographs
were routinely performed. Hematological and biochemi-
cal markers including a complete blood count, diﬀeren-
tial white cell count, and levels of CRP, TNF-α,I L - 1 β,
PCT, and SAA were serially measured. The initial (2mL)
blood samples were obtained from patients on day 0
(at the time of sepsis diagnosis). Two further samples
were obtained from each patient on days 4 and 8 for
follow-up in the patient group. However, only one blood
sample (2mL) was obtained from each healthy control
subject.
Serum CRP levels were measured by radio-immuno-
assay method (cut-oﬀ level: 0.8mg/dL). TNF-α (cut-oﬀ
level: 1pg/mL), IL-1β, and SAA (cut-oﬀ level: 6610ng/mL)
levels were measured by ELISA (BioSource International
Immunoassay, BioSource International, Inc., Calif, USA).
PCT (cut-oﬀ level: 0.8ng/mL) levels were analyzed by
immunoluminometric method (Brahams PCT LUMItest,
BRAHAMS-Hennigsdorf, Berlin, Germany). Blood speci-
mens for TNF-α,I L - 1 β, PCT, and SAA were immediately
immersed in ice and transported to the laboratory for
processing. Serum was separated by centrifugation at 4◦C
and stored in 200μL aliquots at −72◦C until analysis.
The receiver operator characteristic (ROC) method was
usedtodeterminethebestcut-oﬀpointofCRP,TNF-α,PCT ,
and SAA.
The study was approved by the Research Ethics Commit-
tee of the Faculty of Medicine, Eskisehir Osmangazi Univer-
sity. Informed consents were obtained from the parents or
guardians for all study patients and control subjects.
Statistical analyses were performed using SPSS 10.0.χ2,
post hoc and Mann Whitney-U tests were used to compare
categorical predictors. Also, multivariate analyses were per-
formed for logistic regression analysis. The sensitivity and
speciﬁcitywerecalculatedfordays0,4,and8toconstructthe
receiver operating characteristic curves for each biochemical
marker.
3. RESULTS
The demographic characteristics of the study and control
groups are summarized in Table 1. There were no signiﬁcant
diﬀerences between the two groups for gestational age, sex,
birthweight,orApgarscoresat1and5minutes.Clinical and
laboratory ﬁndings of the study group are given in Table 2.
Hypotonia,changesinbodytemperature,cutismarmoratus,
dyspnoea, and hepatomegaly were dominant ﬁndings in
patients with sepsis. Platelet counts (Mean ± SEM) and I/T
ratios(Mean±SEM)werehigherinpatientsthanincontrolsBirsen Ucar et al. 3
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Figure 1: Serum levels of CRP, PCT, TNF-α,a n dS A Ao nd a y s0 ,4 ,a n d8 .
Table 3: Serum levels of acute phase reactants in newborns with culture-proven sepsis and controls (mean ± SD).
Patients Controls
Day 0 Day 4 Day 8
Procalcitonin (ng/mL) 89.7 ±30.3∗∗∗ 50.7 ±16.8∗∗∗ 62.7 ±18.7∗∗∗∗ 1.5 ±0.1
TNF-α (pg/mL) 161.9 ±78.4∗ 86.7 ±28.6∗∗∗ 144.8 ±58.2∗∗ 9.3 ±4.4
IL-1β (pg/mL) <1 <1 <1 <1
SAA (ng/mL) 5529.6 ±375.5 5671.5 ± 367 5643.5 ±436.2 5461.1 ±407.5
CRP (mg/dL) 10.4 ±1.1∗∗∗ 8.4 ± 1∗∗∗ 7.3 ±1.1∗∗∗ 0.8 ±0.1
∗P<. 05; ∗∗P<. 01; ∗∗∗P<. 001; ∗∗∗∗P<. 0001.
(46777.8 ± 10720.6/mm3 versus 215000 ± 47600/mm3; P<
.001 and 0.2 ± 0.1v e r s u s0 .002 ± 0.004; P<. 001; resp., but
leukocyte counts (Mean ± SEM) were similar in patients and
controls19294.4±8598/mm3 versus46777.8±10720.6/mm3;
P>. 05).
During the study period, 28 (77.8%) patients were
treated with mechanical ventilation. Eight out of these 28
(28.6%)patientshadrespiratorydystresssyndromeandwere
treated with surfactant. Thirty of 36 (83.3%) patients were
given oxygen therapy. None of the patients had been treated
with pre-/postnatal antibiotics or steroids and none of them
had been operated prior to the inclusion to the study. Also
none of the patients had a central line.
The ratio of blood culture-proven septic patients among
the study group was 72.2%. Klebsiella pneumonia was the
most prevalent microorganism in the septic patients.
Individual serum levels of PCT, SAA, CRP, TNF-α,a n d
IL-1β in the whole patient group and control group on
days 0, 4, and 8 are shown in Figure 1.H o w e v e r ,Table 3
demonstrates serum levels of acute phase reactants in the
patients with proven sepsis and controls. The serum levels
of CRP, PCT, and TNF-α in the whole patient group on day
0 were found to be signiﬁcantly greater than the controls
(Figure 1, P = .001). Also, serum levels of CRP, PCT, and
TNF-α in the patients with proven sepsis on day 0 were
found to be signiﬁcantly higher than in controls. These high
levels were continued on days 4 and 8. On the other hand,
serum levels of IL-1β were not higher in the patient group on
days 0, 4, and 8 than the control group. The mean levels of
SAA of the study group were found to be greater than that
of the control group but the diﬀerence was not statistically
signiﬁcant (P>. 05).
While PCT levels on day 0 were signiﬁcantly higher than
on day 4 (P<. 05), there were no signiﬁcant diﬀerences
between PCT levels on day 4 and day 8 or day 0 and day 8
(P>. 05). TNF-α and SAA levels did not change statistically
during the study period (P>. 05). CRP levels on day 0 were
signiﬁcantly higher than on day 4 and day 8 (P = .05 and
P = .01, resp.). However, CRP levels on day 4 and day 8 were
similar (P>. 05).4 Mediators of Inﬂammation
TSS did not correlate with the serum levels of PCT, SAA,
CRP, TNF-α,I L - 1 β, or hematological values including I/T
ratio, leukocyte, and thrombocyte counts (P>. 05). Also,
the serum levels of PCT, SAA, CRP, TNF-α,o rI L - 1 β did not
c o r r e l a t ew i t hp l a t e l e tc o u n t s( P>. 05).
The serum levels of CRP negatively correlated with the
levels of SAA and positively correlated with TNF-α on day 0
(r =− 0.532, P<. 001; r = 0.393, P<. 05, resp.) and with
the levels of SAA on day 4 (r =− 0.481, P<. 01). In addition,
the levels of SAA on day 0 positively correlated with the ratio
of I/T (r = 0.40, P<. 05).
Multipleregressionanalysisshowedthatthemostimpor-
tant factor which inﬂuenced the levels of CRP on days
0, 4, and 8 was TNF-α level (r = 0.896, P = .001;
r = 0.621, P<. 05; r = 0.634, P<. 01, resp.). The
sensitivity and speciﬁcity of PCT, SAA, CRP, and TNF-
α for determining sepsis are summarized in Table 4.T h e
sensitivity and speciﬁcity of the acute phase reactants on
day 0 were CRP (97.2%; 95% CI: 85.4–99.5 and 100%;
95% CI: 100.0-100.0), PCT (86.1%; 95% CI: 70.5–95.3 and
97.2%; 95% CI: 85.4–99.5), TNF-α (83.3%; 95% CI: 67.2–
93.6 and 80.6%; 95% CI: 64.0–91.8), SAA (75%; 95% CI:
57.8–87.9 and 44.4%; 95% CI: 27.9–61.9, resp.). Based on
these analyses, the most sensitive parameter was CRP on day
0. Other sensitive parameters were PCT, TNF-α, and SAA,
respectively, on day 0.
The ROC curves of PCT, SAA, CRP, and TNF-α are seen
in Figure 2.
Threepatients(8.3%)diedduetosystemicinﬂammatory
responsesyndrome.Oneofthemhadhydropsfetalisandtwo
others had respiratory dystress syndrome and also all these
three patients had disseminated intravascular coagulation
(DIC). Interestingly, we did not ﬁnd any signiﬁcant increase
inthelevelsofTNF-αandSAAinthispatientsincomparison
to those who survived, but high levels of PCT were found in
these patients on days 0, 4, and 8 than the control group (90
± 7.8/1.5±0.1; 42.2±8.3/1.5±0.1; 56.3±7.2/1.5±0.1, resp.,
P<. 001).
4. DISCUSSION
Culture-proven bacterial infections in newborn infants are
associated with substantial morbidity and mortality. How-
ever, a single reliable biochemical marker is not available for
the diagnosisof neonatal sepsis. SAA has been proposed for
early diagnosis of NLS [4, 5, 9, 10]. Arnon et al. reported that
SAA had an overall better diagnostic accuracy for predicting
early onset sepsis than CRP (sensitivity (96% versus 30%),
speciﬁcity (95% versus 98%)) [4]. Also, they found that SAA
was a useful inﬂammatory marker during late-onset sepsis in
preterm infants [5]. In contrast to these studies in our study,
SAA levels were greater in patients with late-onset neonatal
sepsis than in the control group on days 0, 4, and 8; but this
diﬀerence was not statistically signiﬁcant (P>. 05). These
results may explain defective IL-1β production in newborn.
In fact, it has been reported that SAA gene transcription is
induced mainly by glucocorticoids, IL-1, IL-6, and TNF-α
[11]. However, Gabay et al. [12] reported that IL-1 and IL-6
butnotTNF-αcouldinduceSAAproteinsynthesisinhuman
hepatocytes and that IL-6 was the most eﬀective inducer
but synergy with either IL-1 or TNF-α was not seen [12].
Our experience showed that IL-1 does not increase in septic
newborns and TNF-α seems not to inﬂuence the production
ofSAAinsepticnewborns.Therefore,theproductionofSAA
may not be adequately stimulated in newborn. Like IL-1, we
do not propose the use of SAA as an acute phase reactant in
NLS.
Although, in recent years, several new markers of infec-
tion have been investigated, some studies suggested that CRP
remains to be the best diagnostic test for neonatal sepsis.
Especially serial measurements of CRP are highly speciﬁc
and sensitive in newborn sepsis [12–16]. Also, our results
showedthatCRPisthebestsensitiveandspeciﬁcacutephase
reactant for diagnosis of NLS.
Our data indicated that the plasma concentrations of
IL-1β in infected infants were remarkably low and IL-1β
was a less satisfactory marker. It seems that the monocytes
of newborn infants may be unable to secrete adequate IL-
1β and prostaglandin E2 (fetal or maternal) and IL-6 may
suppress IL-1β and TNF-α production in infections [17–20].
Therefore, we do not propose the use of IL-1β as an acute
phase reactant in NLS.
TNF-α is one of the primary agents which sets in
motion the exaggerated cellular, metabolic, and vascular
responses of sepsis [21–23]. Its usefulness as a diagnostic
marker has not been found to be as good as either SAA
or IL-1 in other studies and the sensitivity and speciﬁcity
have been controversial in neonatal sepsis [13, 17, 24].
In one study, the sensitivity and speciﬁcity were found to
be 87.9% and 43%, respectively, with high positive and
negative predictive values [17]. In our study, it was found
that the sensitivity and speciﬁcity of TNF-α were 83.3%
and 80.6%, respectively, on day 0. We found that the levels
of TNF-α positively correlated with the serum levels of
CRP on day 0. So that TNF-α is also a useful marker
with high sensitivity and speciﬁcity for the detection of
NLS.
A few new of markers including PCT seem to be
promising as a diagnostic test for sepsis [3, 6, 25–29]. Some
studies found that the sensitivity of PCT is low (70%–
80%) to rule out sepsis at birth [25, 28]. Indeed, Enguix
et al. [6] reported that PCT, CRP, and SAA are similar
diagnostic markers of sepsis in critically ill neonates. In
contrast to these reports, in our study, the order of the
markers according to sensitivity and speciﬁcity for optimum
prediction of neonatal sepsis is CRP > PCT > TNF-α>
SAA at the time of diagnosis. Therefore, we found that
PCT was the second useful diagnostic marker in sepsis after
CRP.
Our study conﬁrmed previous ﬁndings that neonates
with bacterial sepsis have reduced thrombocyte count, high
I/T ratio and presence of toxic granulation in granulocytes
[28,29],butleukocytecountswerenotfoundtobeincreased
inourstudy.Alsowefoundthattherewasnotanycorrelation
between TSS and acute phase reactants or hematological
parameters. Caksen et al. [30] reported that there was not
a signiﬁcant diﬀerence for leukocyte counts, cytokine levels,
and TSS between the blood culture-positive and -negativeBirsen Ucar et al. 5
Table 4: The sensitivity and speciﬁcity of acute phase reactants.
Sensitivity (%) Speciﬁcity (%)
Day 0 Day 4 Day 8 Day 0 Day 4 Day 8
Procalcitonin 86.1 83.3 69.4 97.2 86.1 97.2
TNF-α 83.3 80.6 86.1 80.6 80.6 80.6
CRP 97.2 100.0 100.0 100.0 100.0 100.0
SAA 75.0 86.1 19.4 44.4 33.3 100.0
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Figure 2: ROC curves and cut-oﬀ levels of CRP, PCT, TNF-α, and SAA.
groups in septic newborns. We consider that T¨ ollner sepsis
score is itself not helpful in early diagnosis of neonatal
bacterial infections.
In conclusion, our data indicate that CRP is the best
reliable marker of inﬂammation for the diagnosis of NLS.
PCT may also be used as a sensitive and speciﬁc diagnostic
marker in NLS. The SAA did not increase in early phase
in our patients, therefore it cannot be used alone for the
diagnosis and followup of NLS. Also, TSS is not beneﬁcial
in late-neonatal sepsis.
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